Emotive has appointed Terri Cooper as Chair of the Board and Mark Swindell as Non-Executive Director.
Terri and Mark bring significant leadership experience in the life sciences and healthcare consulting sectors to their new roles. Terri has more than 35 years of expertise in these areas, with previous roles including Global Healthcare Sector Leader at Deloitte US, during which time she led the establishment of the firm’s life sciences R&D practice. Terri also has significant advisory experience. She is a Board Trustee at Simmons University, a Trustee at LifeArc and Chairperson of the Board at VersoBiosense.
Mark previously spent more than 14 years at Pfizer, in roles including President Vaccines, Regional President, Asia Pacific and Vice President, Business Assessment. He works as an independent consultant for the life sciences industry and is a consultant and Head of COVAX Transactions Team at Gavi, the Vaccine Alliance.
Chris Edmonds, chief executive of Emotive, said: “Following another strong year of progress for Emotive, these senior appointments will support the next exciting phase of evolution for our global operation – headquartered in London – and for our US business, which is run from Boston, Massachusetts.
“Terri and Mark have both lived and worked extensively in the US and UK, leading large, complex teams across consultancy and the pharmaceutical industry. Their international perspective and depth of leadership experience will be invaluable as we continue to scale the agency globally.”